NCT07428824Recruiting
Effects Of Functional Action Observation With Auditory Cueing In Stroke Patients
Effects of Functional Action Observation Therapy With Rhythmic Auditory Cueing on Balance and Gait in Patients With Stroke
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
This study aims to determine the effects of functional action observation therapy with and without rhythmic auditory cueing on balance and gait in patients with stroke. A randomized clinical trial will be conducted at Ittefaq Hospital Trust, Lahore and Alara Healthcare Clinic. The sample size will be 40. The non-probability convenience sampling methodology will be used to select participants who match the inclusion criteria and the online randomization will be used to further randomize them.Participants will be divided into 2 groups, 20 patients in clinical group and 20 patients in experimental group. While the clinical group will receive traditional therapy, the experimental group will receive Funtional Action Observation Therapy with auditory cueing. For four weeks, the subjects underwent 30 minutes of FAO or general action observation (GAO) instruction five times a week. The outcome measures will include assessments of balance and gait using Berg Balance Scale and Functional Gait Assessment. Assessments will be conducted on patients both before and after the intervention to identify any notable variations in their gait and balance
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 8 Dec 2025
- Start date
- 5 Nov 2025
- Primary completion date
- 12 Apr 2026
- Lead sponsor
- Riphah International University
- Diseases
- Stroke
- NCT number
- NCT07428824
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 5 Nov 2025 to the primary completion date, 12 Apr 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- hospitalization in the previous three months
Other illness
- a positive history of neoplasms, cardiovascular disease, respiratory disease clinically significant muscular-skeletal disease
Other
- Subjects with MMSE score less than 25
- uncorrected visual or auditory disturbances
- Patients with aggressive behavioral alterations or emotional lability
Who the study is looking for
- Age 40 to 60 years
- Both male and female patients are included in the study
- 6 months to 2 years since the onset of stroke
- Ability to sit and stand up independently
- Ability to walk more than 10 m, with or without an assistant device
- No orthopedic impairments on both lower
Age in the registry: 40 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ittefaq Hospital (Trust), Lahore Coordinator of this site? Confirm its status | Lahore | Pakistan | Recruiting |
| Alara Healthcare Clinic Coordinator of this site? Confirm its status | Lahore | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.